ATE500505T1 - Enzymhemmungsimmunverfahren - Google Patents
EnzymhemmungsimmunverfahrenInfo
- Publication number
- ATE500505T1 ATE500505T1 AT04000298T AT04000298T ATE500505T1 AT E500505 T1 ATE500505 T1 AT E500505T1 AT 04000298 T AT04000298 T AT 04000298T AT 04000298 T AT04000298 T AT 04000298T AT E500505 T1 ATE500505 T1 AT E500505T1
- Authority
- AT
- Austria
- Prior art keywords
- enzyme inhibition
- analyte
- inhibition immune
- present
- immune procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
- C07J19/005—Glycosides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
- G01N33/5735—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes co-enzymes or co-factors, e.g. NAD, ATP
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9453—Cardioregulators, e.g. antihypotensives, antiarrhythmics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/904—Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Steroid Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/341,692 US6811998B2 (en) | 1999-06-25 | 2003-01-14 | Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE500505T1 true ATE500505T1 (de) | 2011-03-15 |
Family
ID=32594824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04000298T ATE500505T1 (de) | 2003-01-14 | 2004-01-09 | Enzymhemmungsimmunverfahren |
Country Status (7)
Country | Link |
---|---|
US (3) | US6811998B2 (de) |
EP (1) | EP1441224B1 (de) |
JP (2) | JP4184986B2 (de) |
AT (1) | ATE500505T1 (de) |
CA (1) | CA2455097C (de) |
DE (1) | DE602004031571D1 (de) |
ES (1) | ES2360699T3 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6811998B2 (en) * | 1999-06-25 | 2004-11-02 | Roche Diagnostics Operations, Inc. | Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase |
US7724740B1 (en) * | 2002-08-27 | 2010-05-25 | 3Com Corporation | Computer system and network interface supporting class of service queues |
US20050164330A1 (en) * | 2004-01-27 | 2005-07-28 | Daiichi Pure Chemicals Co., Ltd. | Method for quantitatively determining a specific component in a biological specimen, and reagent for quantitative determination |
US20090215993A1 (en) * | 2007-11-14 | 2009-08-27 | Mitali Ghoshal | Mycophenolic acid immunogens and antibodies |
US9938316B2 (en) | 2013-08-29 | 2018-04-10 | Yeda Research And Development Co. Ltd. | Selective inhibitors of α2 isoform of Na,K-ATPase and use thereof for reduction of intra-ocular pressure and as cardiotonic agents |
WO2017013637A1 (en) * | 2015-07-19 | 2017-01-26 | Yeda Research And Development Co. Ltd. | Selective inhibitors of alpha2-containing isoforms of na,k-atpase and use thereof for reduction of intraocular pressure |
US10668094B2 (en) | 2015-07-19 | 2020-06-02 | Yeda Research And Development Co. Ltd. | Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure |
EP3421050A1 (de) * | 2017-06-30 | 2019-01-02 | Helmholtz-Zentrum für Infektionsforschung GmbH | Aminoglykosidderivate und nano-anordnungen davon, einschliesslich solchen mit quorum-sensing-hemmender funktion |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1595101A (en) | 1925-07-01 | 1926-08-10 | American Assembling Machine Co | Method of and machine for assembling signatures |
US4134792A (en) * | 1976-12-06 | 1979-01-16 | Miles Laboratories, Inc. | Specific binding assay with an enzyme modulator as a labeling substance |
GB1595101A (en) | 1977-03-15 | 1981-08-05 | Hoffmann La Roche | Enzyme modifier immunoassay |
US4273866A (en) | 1979-02-05 | 1981-06-16 | Abbott Laboratories | Ligand analog-irreversible enzyme inhibitor conjugates and methods for use |
US4341865A (en) | 1980-07-21 | 1982-07-27 | Abbott Laboratories | Determination of thyroxine binding globulin |
US4510251A (en) | 1982-11-08 | 1985-04-09 | Abbott Laboratories | Fluorescent polarization assay for ligands using aminomethylfluorescein derivatives as tracers |
US5665583A (en) | 1988-08-12 | 1997-09-09 | Arch Dev Corp | Methods and materials relating to IMPDH and GMP production |
ATE154135T1 (de) | 1989-03-10 | 1997-06-15 | Hoffmann La Roche | Reagenzien zum nachweis von drogen |
US5352803A (en) | 1992-03-30 | 1994-10-04 | Abbott Laboratories | 5(6)-methyl substituted fluorescein derivatives |
US5283257A (en) | 1992-07-10 | 1994-02-01 | The Board Of Trustees Of The Leland Stanford Junior University | Method of treating hyperproliferative vascular disease |
WO1994012184A1 (en) | 1992-11-24 | 1994-06-09 | Syntex (U.S.A.) Inc. | Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis |
US5493030A (en) | 1994-02-18 | 1996-02-20 | Syntex (U.S.A.) Inc. | 5-substituted derivatives of mycophenolic acid |
US5380879A (en) | 1994-02-18 | 1995-01-10 | Syntex (U.S.A.) Inc. | Derivatives of mycophenolic acid |
US5525602A (en) | 1994-02-18 | 1996-06-11 | Syntex (U.S.A.) Inc. | Method of using 4-amino 6-substituted mycophenolic acid and derivatives |
US5512568A (en) | 1994-02-18 | 1996-04-30 | Syntex (U.S.A.) Inc. | Method of using 4-amino derivatives of 5-substituted mycophenolic acid |
US5444072A (en) | 1994-02-18 | 1995-08-22 | Syntex (U.S.A.) Inc. | 6-substituted mycophenolic acid and derivatives |
US6225073B1 (en) | 1994-07-07 | 2001-05-01 | Dade Behring Marburg Gmbh | Immunoassay for mycophenolic acid |
US5756771A (en) | 1995-04-13 | 1998-05-26 | Abbott Laboratories | 5(6)-methyl substituted fluorescein derivatives |
US5807876A (en) | 1996-04-23 | 1998-09-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of IMPDH enzyme |
US6128582A (en) | 1996-04-30 | 2000-10-03 | Vertex Pharmaceuticals Incorporated | Molecules comprising an IMPDH-like binding pocket and encoded data storage medium capable of graphically displaying them |
US6153398A (en) | 1997-12-24 | 2000-11-28 | The University Of Chicago | Method to identify specific inhibitors of IMP dehydrogenase |
US6420403B1 (en) * | 1998-10-29 | 2002-07-16 | Edwin J. Iwanowicz | Inhibitors of IMPDH enzyme |
AU764479B2 (en) * | 1998-10-29 | 2003-08-21 | Bristol-Myers Squibb Company | Compounds derived from an amine nucleus that are inhibitors of IMPDH enzyme |
JP2000310638A (ja) * | 1999-04-28 | 2000-11-07 | Fuji Photo Film Co Ltd | 均一系酵素免疫分析方法 |
US6107052A (en) * | 1999-06-09 | 2000-08-22 | Roche Diagnostics Corporation | Enzymatic measurement of mycophenolic acid |
US6811998B2 (en) * | 1999-06-25 | 2004-11-02 | Roche Diagnostics Operations, Inc. | Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase |
CA2341263C (en) * | 1999-06-25 | 2006-08-01 | Roche Diagnostics Corporation | Enzyme inhibition immunoassay |
US6524808B1 (en) * | 1999-06-25 | 2003-02-25 | Roche Diagnostics Corporation | Enzyme inhibition immunoassay |
EP1207394B1 (de) * | 2000-11-14 | 2009-12-30 | Roche Diagnostics GmbH | Immunoassay für HIV-Protease-Hemstoffe |
-
2003
- 2003-01-14 US US10/341,692 patent/US6811998B2/en not_active Expired - Fee Related
-
2004
- 2004-01-09 DE DE602004031571T patent/DE602004031571D1/de not_active Expired - Lifetime
- 2004-01-09 AT AT04000298T patent/ATE500505T1/de active
- 2004-01-09 EP EP04000298A patent/EP1441224B1/de not_active Expired - Lifetime
- 2004-01-09 ES ES04000298T patent/ES2360699T3/es not_active Expired - Lifetime
- 2004-01-09 JP JP2004004171A patent/JP4184986B2/ja not_active Expired - Fee Related
- 2004-01-12 CA CA002455097A patent/CA2455097C/en not_active Expired - Fee Related
- 2004-07-27 US US10/900,447 patent/US7235675B2/en not_active Expired - Fee Related
-
2006
- 2006-12-06 JP JP2006329870A patent/JP4648891B2/ja not_active Expired - Fee Related
-
2007
- 2007-02-09 US US11/673,180 patent/US7476727B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2004239894A (ja) | 2004-08-26 |
EP1441224B1 (de) | 2011-03-02 |
US6811998B2 (en) | 2004-11-02 |
EP1441224A3 (de) | 2005-05-25 |
JP2007126466A (ja) | 2007-05-24 |
EP1441224A2 (de) | 2004-07-28 |
US20070142631A1 (en) | 2007-06-21 |
CA2455097A1 (en) | 2004-07-14 |
JP4184986B2 (ja) | 2008-11-19 |
CA2455097C (en) | 2009-08-25 |
ES2360699T3 (es) | 2011-06-08 |
US20050009076A1 (en) | 2005-01-13 |
US7235675B2 (en) | 2007-06-26 |
DE602004031571D1 (de) | 2011-04-14 |
US7476727B2 (en) | 2009-01-13 |
JP4648891B2 (ja) | 2011-03-09 |
US20030207431A1 (en) | 2003-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE384952T1 (de) | Enzymhemmungsimmunverfahren | |
BR0116719A (pt) | Biossensores tendo aplicação de amostra aperfeiçoada | |
WO2004113912A8 (en) | System and method for determining a temperature during analysis of biological fluid | |
SE0000538D0 (sv) | Methods and kits for proximity probing | |
RU2008136193A (ru) | Детектирование рака по повышенным уровням bcl-2 | |
KR100711046B1 (ko) | 대장암에 대한 마커로서의 니코틴아미드n―메틸트랜스퍼라아제의 용도 | |
CY1107490T1 (el) | Μεθοδος για την ταυτοποιηση δειγματος σε θηλαστικα καθως και κιτ για την εκτελεση αυτης της μεθοδου | |
ATE509119T1 (de) | Verfahren zum testen von glykosyliertem protein | |
DE60312513D1 (de) | Zusammensetzungen und verfahren zum nachweis vom apo-b48 und apo-b100 | |
WO2003023051A3 (en) | Lateral flow test format for enzyme assays | |
DE602004021281D1 (de) | Kolorimetrische substrate, kolorimetrische sensoren und verwendungsverfahren | |
DE60143355D1 (de) | Verbessertes einfangen und detektion von zielnukleinsäuren in verfahren mit teststreifen | |
DE60029413D1 (de) | Enzymatische messung von mycophenolsäure | |
DK1557473T3 (da) | Reagenssammensætning til at skelne beta-lactamaser, kit og fremgangsmåde dermed | |
DE60310012D1 (de) | Verfahren, Assay und Kit zur Quantifizierung von HIV-Proteasehemmer | |
ATE500505T1 (de) | Enzymhemmungsimmunverfahren | |
DE602005013430D1 (de) | Verwendung von asc als marker für kolorektalkarzinome | |
DE50110174D1 (de) | Verfahren und testkit zum nachweis von analyten in einer probe | |
DE602004017317D1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
ATE368222T1 (de) | Entglykosilierte enzymen für konjugaten | |
EP1342791A3 (de) | Reagenzien, Methode und Apparat zur Messung von Amylase Aktivität | |
DE602004001994D1 (de) | Verwendung des proteins masp als marker für kolorektale karzinome | |
ATE434668T1 (de) | Methode zur messung von amylase aktivität | |
ATE322687T1 (de) | Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1 | |
ATE430317T1 (de) | Enzymatische messung von imatinib-mesylat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1441224 Country of ref document: EP |